MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Putaminal Diffusion Imaging for the Differential Diagnosis of the Parkinsonian Variant of Multiple System Atrophy from Parkinson’s Disease: Impact of Segmentation Accuracy

    R. De Marzi, S. Bajaj, F. Krismer, B. Larcher, S. Ringler, G. Wenning, M. Schocke, W. Poewe, K. Seppi (Innsbruck, Austria)

    Objective:  To evaluate different approaches of segmentation of the putamen in order to discriminate PD from MSA-P based on putaminal diffusion imaging. Background: Differences in prognosis…
  • 2017 International Congress

    In vivo evaluation of tau and amyloid pathology in Corticobasal Syndrome

    F. Niccolini, H. Wilson, S. Hirschbichler, G. Pagano, R. Erro, T. Yousaf, A. Whittington, J. Holton, D. Martino, E. Rabiner, R. Gunn, K. Bhatia, M. Politis (London, United Kingdom)

    Objective: To assess in vivo, with molecular imaging the brain distribution of tau aggregates ([18F]AV1451 PET) and β-amyloid depositions ([18F]AV45 PET) in patients with Corticobasal…
  • 2017 International Congress

    PBB3 Imaging in Parkinsonian disorders: evidence for binding to abnormally aggregated proteins in addition to tau proteins

    A. Perez-Soriano, J. Arena, V. Sossi, K. Dinelle, Q. Miao, J. McKenzie, N. Neilson, A. Puschmann, P. Schaffer, H. Shinotoh, J. Smith-Forrester, E. Shahinfard, N. Vafai, D. Wile, Z. Wszolek, M. Higuchi, A.J. Stoessl (Vancouver, BC, Canada)

    Objective: To study selective regional binding for tau pathology in vivo, using PET with [11C]PBB3 ([11C]methylamino pyridin-3-yl buta-1,3-dienyl benzo[d]thiazol-6-ol) in tauopathies, and in conditions not…
  • 2017 International Congress

    Pattern of MRI findings in ephedronic encephalopathy

    M. Okujava, F. Todua, M. Janelidze, I. Khatiashvili (Tbilisi, Georgia)

    Objective: Objective of  the study was to summarize the typical neuroradiological picture of ephedronic encephalopathy and its clinical correlates. Background: Methcathinone (Ephedrone, Jeff etc.) emerged as…
  • 2017 International Congress

    Voxel-based Analysis of Cholinesterase Inhibitor Response in Lewy Body Disorders: A Prospective Observational Study

    J. Compagnone, H. Mustaerts, J. Li, M. Freedman, K. Galit, J. Lee, J. Kennedy, R. Chen, D. Tang-Wai, A. Lang, N. Herrmann, S. Black, M. Masellis (Toronto, ON, Canada)

    Objective: The objective is to investigate functional neuroimaging correlates of response to ChEIs in LBD. Background: Lewy body disorders (LBD), including dementia with Lewy bodies…
  • 2017 International Congress

    Middle cerebellar peduncle width in multiple system atrophy

    F. Krismer, S. Bajaj, G. Wenning, C. Scherfler, W. Poewe, M. Schocke, A. Hussl, K. Seppi (Innsbruck, Austria)

    Objective: To evaluate the diagnostic accuracy of middle cerebellar peduncle (MCP) width measurements in the differential diagnosis of neurodegenerative parkinsonian disorders including multiple system atrophy…
  • 2017 International Congress

    Volumetric analysis of limbic structures in patients with functional movement disorders

    C. Maurer, K. LaFaver, G. Limachia, G. Capitan, S. Horovitz, M. Hallett (Bethesda, MD, USA)

    Objective: To evaluate amygdala and hippocampal volume in patients with functional movement disorders (FMD). Background: Functional neuroimaging studies in patients with FMD have demonstrated abnormalities…
  • 2017 International Congress

    Presence of abnormalities on structural MRI associate with faster disease progression in multiple system atrophy

    K. Seppi, F. Krismer, G. Wenning, S. Papapetropoulos, V. Abler, W. Poewe (Innsbruck, Austria)

    Objective: To identify MRI markers that are associated with more rapid clinical progression in multiple system atrophy (MSA) Background: The rate of clinical progression in…
  • 2017 International Congress

    Brain iron accumulation in Wilson disease measured by quantitative susceptibility mapping

    P. Dusek, M. Dezortova, V. Herynek, J. Acosta-Cabronero, L. Kotackova, D. Zahorakova, S. Robinson, F. Jiru, R. Bruha, Z. Marecek, M. Hajek (Praha, Czech Republic)

    Objective: To investigate whether cerebral iron deposits in Wilson disease (WD) patients are associated with decreased serum ceruloplasmin oxidase activity and/or clinical severity.   Background:…
  • 2017 International Congress

    Longitudinal AV-1451 PET imaging in Progressive Supranuclear Palsy and Cortico-Basal Syndrome

    A. Sierowf, M. Grossman, D. Russell, I. Litvan, E. Roberson, A. Boxer, M. Devous, M. Navitsky, I. Kennedy, M. Lu, S. Doyle, M. Pontecorvo, M. Mintun (Philadelphia, PA, USA)

    Objective: To evaluate change in AV-1451 positron emission tomography (PET) imaging in patients with Progressive Supranuclear Palsy (PSP) and Cortico-Basal Syndrome (CBS) over 9 months…
  • « Previous Page
  • 1
  • …
  • 1459
  • 1460
  • 1461
  • 1462
  • 1463
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley